Events

Revolutionizing Clinical Trial Central Monitoring: Automated Quality Assurance for Faster, Scalable Monitoring by Rachel Newsome, PhD Tuesday 22nd October at 15:45  Accurate administration of rater-based clinical instruments, such as the Clinical Dementia Rating (CDR), is critical for reliable clinical outcomes in Alzheimer’s Disease (AD) trials. However, existing gold-standard quality assurance (QA) processes rely heavily or […]

We’re thrilled to have presented our latest research at the ISCTM Autumn Meeting on 12-13 September 2024. Rachel Newsome, PhD shared research into the future of clinical trials with recent validation of AQUA, innovation in cognitive assessments, and cutting-edge methodologies. Download poster If you have any questions or would like to discuss any of our